RecruitingNCT07084480
Giant Cell Arteritis - Ways to Precision Medicine
Riesenzellarteriitis - Wege Zur "Precision Medicine"
Sponsor
Wuerzburg University Hospital
Enrollment
400 participants
Start Date
Nov 14, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Age greater or similar to 18 years
- Primary diagnosis of GCA or PMR
Exclusion Criteria2
- Age under 18 years
- lack of capacity to consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07084480
Related Trials
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT022578661 location
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT068946022 locations
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
NCT054357813 locations
Rheumatology Patient Registry and Biorepository
NCT044020861 location
Abatacept for the Treatment of Giant Cell Arteritis
NCT044748479 locations